After adjustment for age, cirrhosis, microvascular invasion, AFP, and PIVKA-II, MTM subtype remained an independent predictor of early recurrence with borderline statistical significance (adjusted OR = 3.47, 95% CI = 0.88–13.59, p = 0.075). The gene discussed is AFP; the disease is X-linked myotubular myopathy.